Remimazolam Anesthesia for MitraClip Implantation in a Patient with Advanced Heart Failure

Remimazolam, a novel and ultrashort-acting benzodiazepine, has been available for general anesthesia in Japan. The administration of remimazolam does not induce injection pain, has been reported to have less cardiovascular depressant effects during general anesthesia, and flumazenil can antagonize t...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in anesthesiology 2021-05, Vol.2021, p.1-4
Main Authors: Satoh, Tomoe, Nishihara, Noriaki, Sawashita, Yasuaki, Ohno, Sho, Hirata, Naoyuki, Yamakage, Michiaki
Format: Article
Language:English
Subjects:
Anesthesia
Cardiac patients
Case Report
Case reports
Clinical trials
Consciousness
Ejection fraction
Fainting
Flumazenil
General anesthesia
Heart failure
Heart surgery
Hemodynamics
Hypotension
Medical personnel
Patients
Remifentanil
Thoracic surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Remimazolam, a novel and ultrashort-acting benzodiazepine, has been available for general anesthesia in Japan. The administration of remimazolam does not induce injection pain, has been reported to have less cardiovascular depressant effects during general anesthesia, and flumazenil can antagonize the effects of remimazolam. However, in clinical trials, no patient who is complicated with severe heart failure or undergoes cardiac surgery was included. We present anesthetic management with remimazolam for MitraClip® implantation in a patient with severe mitral regurgitation and advanced heart failure. Remimazolam was administered both in anesthetic induction and maintenance with less cardiovascular depressant effects. After surgical procedures were completed, the patient smoothly recovered from anesthesia and the tracheal was extubated just after administration of flumazenil. Remimazolam may be able to achieve appropriate anesthetic management in patients complicated with severe cardiovascular diseases.
ISSN:2090-6382
2090-6390
DOI:10.1155/2021/5536442